MapLight Therapeutics, Inc.

MPLT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$12.55-3.61%

2026-08-03

Financials

Valuation Metrics

MapLight Therapeutics, Inc.'s Market Cap is $569M. At end of 2025 it was $728M. Ranked #2750 of 3,112 in US market (top 88%), #1185 of 1,445 on NASDAQ (top 82%), #218 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 81%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$569M	US#2,750/3,112 Sec#218/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-199M	US—/3,112 Sec—/269
Total Assets	$419M	US#2,810/3,112 Sec#180/269
Net Assets	$400M	US#2,407/3,112 Sec#133/269
Value
P/B	1.42x	US#741/3,112 Sec#35/269
FCF Yield	-28.86%	US—/3,112 Sec—/269
Profitability
ROE	-49.89%	US#2,740/3,112 Sec#173/269
ROA	-47.63%	US#2,959/3,112 Sec#212/269
Financial Health
Debt Ratio	4.74%	US#45/3,112 Sec#16/269
Total Debt	$6M	US#2,841/3,112 Sec#216/269
FCF	$-164M	US#2,695/3,112 Sec#196/269
Cash	$56M	US#2,535/3,112 Sec#218/269
Current Ratio	22.91x	US#109/3,112 Sec#22/269
Performance
1M Return	-66.16%	US#3,110/3,112 Sec#268/269
From 52W High	-68.96%	US#3,009/3,112 Sec#253/269
1Y MDD	-75.13%	US#3,001/3,112 Sec#253/269
Trading
Volume	985,011 shares	US#1,481/3,112 Sec#146/269
Trading Value	$12M	US#2,240/3,112 Sec#178/269
Per Share
EPS	$-1.97	US—/3,112 Sec—/269
BPS	$5.64	US#2,163/3,112 Sec#121/269